Neprinol Clinical Study

An open-label clinical trial was conducted using healthy overweight individuals to determine Neprinol's ability to impact various blood markers within the body. The trial utilized a therapeutic dosage of 9 capsules daily taken over a 12 week period. The results of the study were presented at a Scripps' Conference and were awarded with a first place finish among the other presentations.

To view the press release for this award, click here.

Download the clinical study for more information on the proven results of Neprinol.